BMP2 alterations in mucinous cystadenocarcinoma of the breast: insights from whole-exome sequencing

This study provides new insights into the clinical and molecular features of breast MCA, suggesting that tumor stage is an important prognostic indicator. BMP2 emerged as a potential driver of tumor progression, and its utility as a predictive or prognostic biomarker warrants further investigation in larger cohorts. These findings may pave the way for improved prognostic assessment and novel therapeutic strategies targeting BMP2 in breast MCA.